Exploring the antioxidant and enzyme inhibitory potential of the Streptomycesgobitricini strain: a promising biotechnological resource

Streptomyces strains are renowned for their ability to produce a wide array of secondary metabolites, which play crucial roles in ecological interactions and have significant pharmaceutical applications. The optimization of culture conditions is a key factor in maximizing the production of these bioactive compounds. This study investigated the growth patterns and bioactivity of a newly isolated Streptomyces gobitricini cultured on different media: R5, R5E, R2YE, and YEME. Data showed that R5 and R2YE media supported higher biomass accumulation, achieving peak dry weights of 225 mg/L and 175 mg/L, respectively, after 96 h-incubation, compared to R5E (52 mg/L) and YEME (48 mg/L). Growth phases, especially the exponential phases, were longer and more pronounced in nutrient-rich media like R5 and R2YE. Furthermore, the inherent antioxidant activities, enzyme inhibitory properties against α-amylase, α-glucosidase, lipase, and trypsin, as well as secreted phospholipase A2, cyclooxygenases and lipooxygenase, showed significant variations influenced by the growth media, with R5 exhibiting the highest overall bioactivity. Specifically, R2YE extracts demonstrated potent inhibitory effects on α-glucosidase and phospholipases, while YEME showed promising lipase inhibition. These findings emphasized the critical role of media composition in promoting secondary metabolite production in S. gobitricini, ultimately enhancing its potential medicinal applications for several human diseases such as obesity and inflammation. Consequently, optimizing bacterial culture conditions could significantly improve yield and efficiency of bioactive compounds.